Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04937998

PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT

THE USE OF FRESH PRP VS HA IN THE TREATMENT OF OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT Randomized Controlled Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
166 (estimated)
Sponsor
Istituto Ortopedico Rizzoli · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA

Detailed description

166 patients affected by patellofemoral osteoarthritis will be included in a double-blinded RCT. In this study one group of patients will be treated with 1 intra-articular injection of PRP (treatment arm) and one group will be treated with 1 intra-articular injection of HA (control arm). Patients will be followed-up with clinical evaluation at baseline and at 2.6.12 and 24 months. Questionnaires will be administered for clinical evaluations during the follow-up visits.

Conditions

Interventions

TypeNameDescription
PROCEDUREAutologous PRP injectionPatients will be treated with a single injection of Autologous PRP (5 ml) in the knee joint affected by patellofemoral osteoarthritis
PROCEDUREHA injectionPatients will be treated with a single injections of Hyaluronic Acid (5 ml) in the knee joint affected by patellofemoral osteoarthritis

Timeline

Start date
2022-10-26
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2021-06-24
Last updated
2025-12-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04937998. Inclusion in this directory is not an endorsement.